NEW ORLEANS — Most investigators concluded that telemedicine is satisfactory for patients with schizophrenia being treated with long-acting injectable psychotics, according to survey results presented at the American Psychiatric Association meeting.
O’Sullivan and colleagues set out to evaluate the impact of the COVID-19 pandemic and the role of telepsychiatry on managing this patient population in the fall of 2020.
Co-author Dawn I. Velligan, PhD, of the University of Texas Health Science Center at San Antonio, said this observational study specifically involved patients with